Avacopan for the Treatment of ANCA-Associated Vasculitis
David Jayne(University of Cambridge), Pirow Bekker(ChemoCentryx (United States)), Thomas J. Schall(ChemoCentryx (United States)), Peter A. Merkel(ChemoCentryx (United States))
Cited by 957
Related Papers
Identification of a major co-receptor for primary isolates of HIV-1
|Nature|1996|3.7k
A new class of membrane-bound chemokine with a CX3C motif
|Nature|1997|2k
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
|New England Journal of Medicine|2010|1.7k